TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Muscle breakdown
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number of beneficial cases according to Immunoscore®
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Anxiety levels as measured by the Spence Children's Anxiety Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of adverse events (dose finding cohort)
Endpoint domain: Adverse events/effects
Primary endpoint: Overall response rate (expansion cohort)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amputee Mobility Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Cumulative incidence of clinically significant cytomegalovirus infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proportion of participants achieving a successful outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Practice Frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Practice Automaticity
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Diabetic foot complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: screening rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Bone shell size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective perception of cough
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Objective frequency of cough
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early safety assessment
Endpoint domain: Adverse events/effects
Primary endpoint: Horizontal convergence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative high-sensitive troponin I change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maximum plantar pressure under the first metatarsal head
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relevance of the MNDActiveLive questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: HDL-S1P change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Accuracy of ECG devices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Sleep wake patterns
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Sleep problem
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in percentages of CD3+ T-cell immune cell population
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Mitochondrial activity in CD3+ T-cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glasgow-Blatchford score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MAP score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: H3B2 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Value of qNOX with BPS≥5
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants who enroll and complete the GA
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time for caregivers to complete the GA
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Caregiver satisfaction with completing the GA
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Partial Remission (PR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Stable Disease (SD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Patient-reported changes in acute anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Urinary Kidney Biomarker Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Number of participants with ultrasonographic pattern of emphysema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Viral Load Change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lymph node invasion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of cases of TIBOLA
Endpoint domain: Adverse events/effects
Primary endpoint: NBUT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TMH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MG loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in symptomatic parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in physical parameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in LV function/remodeling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Thenar Muscle Activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median Nerve Conduction Velocity during Phalen's Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Median Nerve Distal Latency during Phalen's Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of fertilization disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Difference in serum potassium levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Participants with Serious Treatment-emergent Adverse Events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: TEAEs Leading to Discontinuation of Study Treatment
Endpoint domain: Adverse events/effects
Primary endpoint: NBI-921352 exposure-efficacy response relationship
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Correct identification of healthiest product
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correct identification of least healthy product
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants reporting a new Grade 3 or greater adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants achieving post-treatment control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Significant Toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Change in standardized office BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: plasma levels of oxytocin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Richmond Agitation Sedation Score (RASS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pittsburgh Agitation Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety Endpoint Acute
Endpoint domain: Adverse events/effects
Primary endpoint: Distance Visual Acuity (VA) with Study Lenses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of SARS-CoV2 antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Ankle circumference at thinnest point (cm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Popliteal heel height (cm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circumference of the calf at the strongest point (cm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circumference of the forefoot at the level of the metatarsal heads (cm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radius of curvature of the head of the first metatarsus (cm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: App engagement metrics
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Mental Health Self-Efficacy Scale (MHSES)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patient-Reported Outcomes Measurement Information System Global Health (PROMIS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Generalized Anxiety Disorder Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of local recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Composite of myocardial infarction, unplanned revascularisation, or all cause mortality
Endpoint domain: Mortality/survival
Primary endpoint: Generalized Anxiety Disorder -7
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time from injury to symptom resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum biomarker concentration: GFAP change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety and depression severity change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Serum Potassium Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in 24 Hour Urine Sodium Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: need for ICU admission
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: combined outcome
Endpoint domain: Physiological/clinical
Primary endpoint: Percentage change in Psoriasis Area and Severity Index (PASI) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Asthma Control test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MRI neuroimaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Disease severity prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary Polyphenol Catabolite Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Urinary Anthocyanin Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fecal Polyphenol Catabolite Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fecal Anthocyanin Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Urine Creatinine Content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total exercise gastrointestinal symptom burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in emotion ratings
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Morphine sulfate equivalent rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: brain microstructural integrity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Effectiveness of cluster headache treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pain EVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Predictive value of High Frequency Algorithm for signals under 0.3mV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Predictive value of High Frequency Algorithm for signals under 0.1mV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oedema detected by MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fibrosis detected by MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of In-Stent Restenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in FeNO values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Reliability of fluid intake measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BMI in early pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Awareness of risk factors for arterial hypertension
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in maternal depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in maternal anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Visual Deficits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood oxygenation level dependent (BOLD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of DLT (Dose-Limiting Toxicity) at week 4
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Adverse Events from baseline to 8 weeks
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of CS-complicated AMI events
Endpoint domain: Mortality/survival
Primary endpoint: Hemostasis of the episiotomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: No edema at the site of episiotomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: No infection at the episiotomy
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical Outcomes in Routine Evaluation
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: RMR (portable indirect calorimeter - BreezingTM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction & feedback (feasibility)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: MOAA/SS (sedation level)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survivorship of EVOLUTION® Revision Tibial Base components
Endpoint domain: Mortality/survival
Primary endpoint: Survivorship of EVOLUTION® STEMMED CS Femoral components
Endpoint domain: Mortality/survival
Primary endpoint: Survivorship of EVOLUTION® MP CS tibial inserts
Endpoint domain: Mortality/survival
Primary endpoint: Clinically significant changes in electrocardiograms (ECGs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinically significant changes in vital signs (pulse)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically significant changes in vital signs (blood pressure)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinically significant changes in safety laboratory parameters (clinical chemistry)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically significant changes in safety laboratory parameters (heamatology)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Heart Rate (pulse)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in ImPACT test scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Euploidy Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of Pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Quality of Life Short Form-36
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Assessment of Functionality
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in lower extremity function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in upper extremity function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in daily functions
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percentage of Participants With Vaccine-Related Serious AEs (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Conservative diagnostic accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: prototype set-up time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Quality of the impedance of each electrode
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of errors during calibration
Endpoint domain: Adverse events/effects
Primary endpoint: Patient/caregiver satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 6 minute walk distance (6MWD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Urinary albumin/creatinine ratio (ACR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in Fasting blood glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Single-leg hop performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Proportion of HCP adherence to treatment algorithm
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Neonatal Pain Diagnostic Scale (NIPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of Magtrace-related skin discoloration
Endpoint domain: Adverse events/effects
Primary endpoint: Percent change in MADRS score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in The Sino-Nasal Outcome Test 22 (SNOTT22) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hemodynamics analysis of Oxygenated Hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hemodynamics analysis of Deoxygenated Hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of green criteria on application feedback
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Upper extremity exercise capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Rate of radiation-associated toxicity (≥ 2 degree)
Endpoint domain: Adverse events/effects
Primary endpoint: 3 months of sustained transfusion reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3 months of transfusion independence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-Care Cognition
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Satisfaction with Educational Materials
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of participants reporting laboratory-confirmed influenza cases with associated influenza-like illness
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Overactive Bladder Symptom Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perception threshold for pulse shape
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensation for pulse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge of emergency management of traumatic dental injuries
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Difference in Time Trial Times
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in Anxiety Measured with the State Trait Anxiety Inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Difference in Blood Lactate Concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Difference in Gastrointestinal Distress
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Different in Heart Rate Variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: global neurological efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Tactile Acuity (The two-point discrimination test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimal Residual Disease (MRD)-negative Complete Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Overall Survival to Transplant, Myocardial Recovery or on Device Support Free of Debilitating Stroke
Endpoint domain: Mortality/survival
Primary endpoint: Cumulative Occurrence of Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Appendicular skeletal mass index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Accuracy of PET CT in diagnosis of lung cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Value of PET CT in staging of lung cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes